Détails du rapport Vaer
Âge: N/A
Genre: Female
Région : Outside US
- Patient décédé?
- Non
- Renseignements sur les vaccins
-
Nom: MENINGOCOCCAL B (TRUMENBA)
Type : Meningococcal group b vaccine, rDNA absorbed
Fabricant: PFIZER
Lot: ex6364
- Date de réception du rapport
- 2022-03-04
- Date à laquelle le formulaire est complèté
- Date de vaccination
- 2022-02-17
- Date d’apparition
- 0
- Nombre de jours (date d’apparition – date de vaccination)
- 0
- Description de l’événement indésirable
-
reports dizziness; heat sensation in the face; erythema on the face (mainly about 10 minutes after vaccination) on the right and left zygomatic region, on the neck; this is a spontaneous report received from a contactable reporter (physician) from the regulatory authority-web. regulatory number: it-minisal02-845162 (ra). a 12 year-old female patient received meningococcal group b rlp2086 (trumenba), intramuscular, administration date: 17feb2022 (lot number: ex 6364) as a single dose for meningococcal immunisation. the patient's relevant medical history and concomitant medications were not reported. vaccination history included: trumenba (j07ah09), administration date: 23jul2021, for meningococcal immunization, reaction(s): "pyrexia nos". the following information was reported: dizziness (hospitalization) with onset 17feb2022, outcome "recovering", described as "reports dizziness"; feeling hot (hospitalization) with onset 17feb2022, outcome "recovering", described as "heat sensation in the face"; erythema (hospitalization) with onset 17feb2022, outcome "recovering", described as "erythema on the face (mainly about 10 minutes after vaccination) on the right and left zygomatic region, on the neck". the patient underwent the following laboratory tests and procedures: blood pressure measurement: (17feb2022) 110 df; radial pulse: (17feb2022) 85 df. reporter comment: vaccination against meningococcus b (second dose) carried out in a deltoid injection. the first dose of vaccine, carried out on 23/07/2021, caused a fever that the mother reported to have regressed after one day following the intake of antipyretic drugs. no follow-up attempts are possible. no further information is expected.; reporter's comments: vaccination against meningococcus b (second dose) carried out in a deltoid injection. the first dose of vaccine, carried out on 23/07/2021, caused a fever that the mother reported to have regressed after one day following the intake of antipyretic drugs
- Données de laboratoire
-
test date: 20220217; test name: blood pressure measurement; test result: 110 {df}; test date: 20220217; test name: radial pulse; test result: 85 {df}
- Liste des symptômes
-
feeling hot erythema dizziness pyrexia
- Patient décédé?
- Non
- Date de décès
- N/A
- Anomalie congénitale
- false
- Vaccin administré par :
- Other
- Vaccin acheté par :
- Inconnu
- Visite d’un patient à l’urgence?
- Non
- Patient hospitalisé?
- Oui
- Séjour à l’hôpital
- Non
- Nombre de jours à l’hôpital
- Non spécifié
- Invalidité permanente?
- Non
- Allergies:
-
na
- Maladie actuelle
-
na